Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Newer Targets
Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody…
Newer Targets
Codiak Presents First Preclinical Data for exoASO, Engineered Exosomes Designed to…
Newer Targets
Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Approval
AstraZeneca’s Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
Phase III
First China-manufactured Trastuzumab Biosimilar HLX02 Global Phase III Trial Met Primary…
Phase II
Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study…
Approval
BRUKINSA (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
AbbVie and Harpoon Expand Partnership with $510 Million Licensing Deal
Acquisitions
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
Deals
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
Commercial
Eli Lilly to Add 100 Employees Following $400 Million Manufacturing Investment
Home
Commercial
Acquisitions
Acquisitions
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Acquisitions
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
Biospace News
-
November 21, 2019
Acquisitions
Roche to Acquire Fibrosis-Focused Promedior for Up to $1.4 Billion
Acquisitions
Kiadis to Restructure Months After Acquiring CytoSen Therapeutics
Acquisitions
Sartorius Signs Agreement to Acquire Select Danaher Life Science Platform Businesses
Acquisitions
Deepening Its Immune-Related Disease Pipeline, Alexion Buys Achillion for $930 Million
Acquisitions
AbbVie Stays Busy While Working to Complete Allergan Acquisition
Biospace News
-
October 11, 2019
0
Acquisitions
PureTech Acquires New Clinical-Stage Program LYT-100 to Treat Lymphedema
Biospace News
-
July 17, 2019
0
Acquisitions
Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma
Biospace News
-
July 10, 2019
0
Acquisitions
Roche’s $4.8 Billion Acquisition of Spark Pushed Back to April 2020
Biospace News
-
July 8, 2019
0
Acquisitions
SIFI announces expansion on the French market with the acquisition of...
Firstwordpharma News
-
July 4, 2019
0
1
2
3
...
16
Page 1 of 16
- Advertisement -
MOST POPULAR
EnGeneIC Announces First Patients with Advanced-Stage Pancreatic Cancer Dosed in Phase...
May 13, 2019
Celgene’s Fedratinib Given Priority Review for Myelofibrosis
March 5, 2019
Under Fire, Biopharma Increases Lobbying Expenses to Influence Opinion and Legislation
April 24, 2019
Medicure Announces Intention to Commence Substantial Issuer Bid
November 4, 2019
Load more
HOT NEWS
Others
Merrimack Discontinues Development of MM-310
Commercial
Layoffs Hit California Biopharma Companies
Deals
Sarepta and Lysogene Announce Exclusive License Agreement for LYS-SAF302, a Late-stage...
Deals
Celgene Pays Exscientia $25 Million up Front for 3-Year AI Research...
